PTC Therapeutics Inc
XBER:BH3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
PTC Therapeutics Inc
XBER:BH3
|
US |
|
S
|
Smith & Nephew PLC
DUS:NPW1
|
UK |
|
Healthcare Realty Trust Inc
NYSE:HR
|
US |
Multiples-Based Value
The Multiples-Based Value for
PTC Therapeutics Inc (BH3) under the Base Case is 57.06 EUR.
Compared with the current market price of 65.5 EUR, the stock appears
Overvalued by 13% .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.